![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
JRSIS Health Care Corporation (PK) | USOTC:JRSSD | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.4322 | 0.00 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or Other Jurisdiction | (Commission File Number) | (I.R.S. Employer | ||
of Incorporation) | Identification No.) |
(Address of Principal Executive Office) (Zip Code)
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) | Name of each exchange on which registered | ||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 4.01 Change in Registrant’s Certifying Accountant
On July 20, 2023 the Board of Directors of JRSIS Health Care Corporation dismissed Centurion ZD CPA & Co. (“Centurion”) from its position as the principal independent accountant for JRSIS Health Care Corporation (the “Company”), effective immediately. The Company does not have an Audit Committee of the Board of Directors.
The audit report of Centurion on the Company’s financial statements for the years ended December 31, 2022 and 2021 did not contain any adverse opinion or disclaimer of opinion or qualification, except that the audit report of Centurion on the Company’s financial statements for the years ended December 31, 2022 and 2021 did contain a modification expressing substantial doubt about the ability of the Company to continue as a going concern. Centurion did not, during the applicable periods, advise the Company of any of the enumerated items described in Item 304(a)(1)(iv) of Regulation S-K.
For the years ended December 31, 2022 and 2021, and the subsequent interim period through July 20, 2023, there was no (i) disagreement between the Company and Centurion on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreement, if not resolved to its satisfaction, would have caused Centurion to make reference to the subject matter of such disagreement in connection with its report. During the same period, there was no “reportable event,” as described in Item 304(a)(1)(v) of Regulation S-K.
In accordance with Item 304(a)(3) of Regulation S-K, the Company requested Centurion to furnish a letter addressed to the Securities Exchange Commission stating whether it agrees with the statements in this 8-K pertaining to Centurion. A copy of the letter is filed as an exhibit to this 8-K.
On July 20, 2023, the Company appointed the firm of ARK Pro CPA & Co (“ARK”) as its independent registered public accounting firm for the fiscal year ending December 31, 2023. At no time during the past two fiscal years or any subsequent period prior to July 20, 2023 did JRSIS Health Care Corporation consult with ARK Pro CPA & Co. regarding any matter of the sort described above with reference to Centurion ZD CPA & Co., any issue relating to the financial statements of JRSIS Health Care Corporation, or the type of audit opinion that might be rendered for JRSIS Health Care Corporation
Item 9.01 Financial Statements and Exhibits
Exhibits
16 | Letter from Centurion ZD CPA & Co. | |
104 | Cover page interactive data file (embedded within the iXBRL document) |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
JRSIS Health Care Corporation | ||
Date: August 7, 2023 |
By: |
/s/ Huang Zhifei |
Huang Zhifei, Chief Executive Officer |
2
Exhibit 16
August 7, 2023
U.S. Securities & Exchange Commission
100 F Street, NE
Washington, DC 20549
U.S.A.
Ladies and Gentlemen:
We have read the statements concerning our firm contained in Item 4.01 of this Form 8-K of JRSIS Health Care Corporation dated and filed with the Securities and Exchange Commission on August 7, 2023 and are in agreement with the statements concerning our firm contained in the first, second, third and fourth paragraphs. We have no basis to agree or disagree with other statements contained therein.
Very truly yours
/s/ Centurion ZD CPA & Co.
Centurion ZD CPA & Co.
Hong Kong, China
Cover |
Jul. 20, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jul. 20, 2023 |
Entity File Number | 1-36758 |
Entity Registrant Name | JRSIS HEALTH CARE CORPORATION |
Entity Central Index Key | 0001597892 |
Entity Tax Identification Number | 46-4562047 |
Entity Incorporation, State or Country Code | FL |
Entity Address, Address Line One | 3/F Building A, Derun Yuan |
Entity Address, Address Line Two | No. 19 Changyi Road |
Entity Address, Address Line Three | Wuguishan |
Entity Address, City or Town | Zhongshan City |
Entity Address, Country | CN |
Entity Address, Postal Zip Code | 528458 |
City Area Code | 86-0760 |
Local Phone Number | 88963658 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | false |
1 Year JRSIS Health Care (PK) Chart |
1 Month JRSIS Health Care (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions